인지 진단 시장 : 부문별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

REPORT HIGHLIGHT

Cognitive Diagnostics Market size was valued at USD 5,390.21 million in 2023, expanding at a CAGR of 27.90% from 2024 to 2032.

Cognitive diagnostic models are a psychometric paradigm for designing and scoring tests to provide a profile of examinee skill mastery rather than just an overall test score. Cognitive diagnostics refers to the assessment and evaluation of cognitive functions, which include memory, attention, language, problem-solving, and other intellectual abilities. This field encompasses various techniques, tools, and technologies used to diagnose cognitive impairments and disorders, such as Alzheimer's disease, dementia, ADHD, and other neurological conditions. Cognitive diagnostics play a crucial role in the management and treatment of cognitive disorders, offering valuable insights into brain health and function. As technology advances, the field is expected to grow, providing more accurate, accessible, and affordable diagnostic options.

Cognitive Diagnostics Market- Market Dynamics

The growing geriatric population and increasing prevalence of cognitive disorders globally are expected to drive the growth of the market

The global demographic landscape is experiencing a swift aging trend, marked by a notable rise in the elderly population. This demographic shift places older adults at an elevated risk for cognitive impairments, including Alzheimer's disease and various forms of dementia. The World Health Organization projects that by the year 2030, one in six individuals worldwide will be aged 60 years or older. Consequently, the population segment aged 60 and above is expected to grow from 1 billion in 2020 to 1.4 billion. Enhanced awareness and advancements in diagnostic methods are contributing to higher rates of identification for cognitive disorders. As diagnostic technologies evolve, more cases are being recognized and diagnosed at earlier stages-additionally, the ongoing technological innovations and the expansion of healthcare infrastructure present significant opportunities for market growth. Nevertheless, the absence of standardization may pose challenges to the market's expansion.

Cognitive Diagnostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 27.90% over the forecast period (2024-2032)

Based on region, North America was the leading revenue generator in 2023

Cognitive Diagnostics Market- Segmentation Analysis:

The Global Cognitive Diagnostics Market is segmented based on Diagnosis, Indication, End-User, and Region.

The market is segmented into eight distinct categories according to Diagnosis: Brain Imaging Tests, Laboratory Testing, Mental Status Testing, Rapid Home Screening Tests, Neuropsychological Testing, Electroencephalogram (EEG), Cognitive Function & Behavioral Tests, and the Neuropsychiatric Inventory Questionnaire (NPI-Q). Each of these diagnostic categories is essential for delivering thorough evaluations and enhancing patient outcomes in the realm of cognitive health.

The market is segmented into two categories according to Indication: Alzheimer's disease, Dementia, and other neurological disorders. Each category includes distinct diagnostic tools and methods for evaluating and treating these conditions.

The market is segmented into two groups according to End-User: Hospitals, Neurology Clinics, Rehabilitation Centers, Academic and Research Institutes, Home Care, and Others. Each end-user group employs different diagnostic tools and techniques customized to their particular requirements and environments.

Cognitive Diagnostics Market- Geographical Insights

The market is geographically spread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further segmented by countries for business purposes. North America leads the market growth, driven by the increasing demand for diagnostic tools and technologies to assess cognitive performance. The region is a pioneer in technological advancements, especially in artificial intelligence (AI) and machine learning. These technologies are being incorporated into cognitive diagnostic tools, improving their precision and effectiveness. A survey conducted by Pew Research revealed that 55% of Americans claim to regularly use AI, while 44% believe they do not use it regularly. Europe follows as the second largest region for market growth, attributed to the rising demand for Personalized Medicine.

Cognitive Diagnostics Market- Competitive Landscape:

The cognitive diagnostics market is fiercely competitive, with a wide array of competitors striving to gain market share through technological advancements, strategic alliances, and product distinctiveness. Organizations are dedicating significant resources to research and development to introduce innovative diagnostic instruments and technologies. This encompasses progress in brain imaging, biomarker analysis, and AI-powered diagnostic systems. Businesses are broadening their market reach by venturing into emerging markets and establishing a presence in regions where there is a growing demand for cognitive diagnostics. This involves establishing new facilities, acquiring local entities, and customizing products to suit regional requirements. Companies set themselves apart by creating unique diagnostic instruments, enhancing precision, user-friendly interfaces, and seamless integration with other healthcare technologies. This includes providing comprehensive diagnostic solutions that address various aspects of cognitive evaluation.

Recent Developments:

C2N Diagnostics, a prominent entity in the field of advanced brain health diagnostics known for its PrecivityAD blood test, which assists in the diagnosis of Alzheimer's disease, has unveiled its latest innovative product. This new offering is expected to significantly improve care for individuals experiencing cognitive impairment: a high-resolution mass spectrometry-based plasma tau multi-analyte assay (p-tau MAA) designated for Research Use Only (RUO).

Cognetivity Neurosciences Ltd., a technology company specializing in brain health screening platforms for medical, commercial, and consumer settings, is excited to share that its leading CognICA tool has proven to be effective in monitoring cognitive function in Alzheimer's disease patients undergoing treatment with the disease-modifying therapy Aduhelm (aducanumab) from Biogen.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL COGNITIVE DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• Cognetivity Neurosciences
• Cognivue
• Cogstate
• Cambridge Cognition
• Diadem
• CN Diagnostics
• Others

GLOBAL COGNITIVE DIAGNOSTICS MARKET, BY DIAGNOSIS- MARKET ANALYSIS, 2019 - 2032

• Brain Imaging Tests
• Magnetic Resonance Imaging (MRI)
• Computerized Tomography (CT)
• Positron Emission Tomography (PET) and PET/CT
• Laboratory Testing
• Cerebrospinal fluid (CSF)
• Blood Tests
• Mental Status Testing
• Mini-Mental State Exam (MMSE)
• Montreal Cognitive Assessment (MoCA)
• Rapid Home Screening Tests
• Neuropsychological Testing
• Electroencephalogram (EEG)
• Cognitive Function & Behavioral Tests
• Neuropsychiatric Inventory Questionnaire (NPI-Q)
• GLOBAL COGNITIVE DIAGNOSTICS MARKET, INDICATION BY - MARKET ANALYSIS, 2019 - 2032
• Alzheimer's disease
• Dementia
• Others neurological disorders

GLOBAL COGNITIVE DIAGNOSTICS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

• Hospitals
• Neurology Clinics
• Rehabilitation Centers
• Academic and Research Institutes
• Home Care
• Others

GLOBAL COGNITIVE DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Cognitive Diagnostics Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Cognitive Diagnostics Market Snippet by Diagnosis
  • 2.1.2. Cognitive Diagnostics Market Snippet by Indication
  • 2.1.3. Cognitive Diagnostics Market Snippet by End-User
  • 2.1.4. Cognitive Diagnostics Market Snippet by Country
  • 2.1.5. Cognitive Diagnostics Market Snippet by Region
• 2.2. Competitive Insights

3. Cognitive Diagnostics Key Market Trends

• 3.1. Cognitive Diagnostics Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Cognitive Diagnostics Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Cognitive Diagnostics Market Opportunities
• 3.4. Cognitive Diagnostics Market Future Trends

4. Cognitive Diagnostics Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Cognitive Diagnostics Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. Cognitive Diagnostics Market Landscape

• 6.1. Cognitive Diagnostics Market Share Analysis, 2023
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Cognitive Diagnostics Market - By Diagnosis

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Diagnosis, 2023 & 2032 (%)
  • 7.1.2. Brain Imaging Tests
    • 7.1.2.1. Magnetic Resonance Imaging (MRI)
    • 7.1.2.2. Computerized Tomography (CT)
    • 7.1.2.3. Positron Emission Tomography (PET) and PET/CT
  • 7.1.3. Laboratory Testing
    • 7.1.3.1. Cerebrospinal fluid (CSF)
    • 7.1.3.2. Blood Tests
  • 7.1.4. Mental Status Testing
    • 7.1.4.1. Mini-Mental State Exam (MMSE)
    • 7.1.4.2. Montreal Cognitive Assessment (MoCA)
  • 7.1.5. Rapid Home Screening Tests
  • 7.1.6. Neuropsychological Testing
  • 7.1.7. Electroencephalogram (EEG)
  • 7.1.8. Cognitive Function & Behavioral Tests
  • 7.1.9. Neuropsychiatric Inventory Questionnaire (NPI-Q)

8. Cognitive Diagnostics Market - By Indication

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Indication, 2023 & 2032 (%)
  • 8.1.2. Alzheimer's disease
  • 8.1.3. Dementia
  • 8.1.4. Others neurological disorders

9. Cognitive Diagnostics Market - By End-User

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
  • 9.1.2. Hospitals
  • 9.1.3. Neurology Clinics
  • 9.1.4. Rehabilitation Centers
  • 9.1.5. Academic and Research Institutes
  • 9.1.6. Home Care
  • 9.1.7. Others

10. Cognitive Diagnostics Market- By Geography

• 10.1. Introduction
  • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
• 10.2. North America
  • 10.2.1. Overview
  • 10.2.2. Cognitive Diagnostics Key Manufacturers in North America
  • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.2.4. North America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 10.2.5. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.2.7. U.S.
    • 10.2.7.1. Overview
    • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.7.3. U.S. Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.2.7.4. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.2.8. Canada
    • 10.2.8.1. Overview
    • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.8.3. Canada Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.2.8.4. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
• 10.3. Europe
  • 10.3.1. Overview
  • 10.3.2. Cognitive Diagnostics Key Manufacturers in Europe
  • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.3.4. Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 10.3.5. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.7. Germany
    • 10.3.7.1. Overview
    • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.7.3. Germany Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.3.7.4. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.8. Italy
    • 10.3.8.1. Overview
    • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.8.3. Italy Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.3.8.4. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.9. United Kingdom
    • 10.3.9.1. Overview
    • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.9.3. United Kingdom Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.3.9.4. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.10. France
    • 10.3.10.1. Overview
    • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.10.3. France Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.3.10.4. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.11. Russia
    • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.11.2. Russia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.3.11.3. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.12. Netherlands
    • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.12.2. Netherlands Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.3.12.3. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.13. Sweden
    • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.13.2. Sweden Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.3.13.3. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.14. Poland
    • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.14.2. Poland Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.3.14.3. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.15. Rest of Europe
    • 10.3.15.1. Overview
    • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
• 10.4. Asia Pacific (APAC)
  • 10.4.1. Overview
  • 10.4.2. Cognitive Diagnostics Key Manufacturers in Asia Pacific
  • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.4.4. Asia Pacific Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 10.4.5. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.7. India
    • 10.4.7.1. Overview
    • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.7.3. India Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.4.7.4. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.8. China
    • 10.4.8.1. Overview
    • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.8.3. China Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.4.8.4. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.9. Japan
    • 10.4.9.1. Overview
    • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.9.3. Japan Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.4.9.4. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.10. South Korea
    • 10.4.10.1. Overview
    • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.10.3. South Korea Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.4.10.4. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.11. Australia
    • 10.4.11.1. Overview
    • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.11.3. Australia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.4.11.4. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.12. Thailand
    • 10.4.12.1. Overview
    • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.12.3. Thailand Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.4.12.4. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.13. Indonesia
    • 10.4.13.1. Overview
    • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.13.3. Indonesia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.4.13.4. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.14. Philippines
    • 10.4.14.1. Overview
    • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.14.3. Philippines Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.4.14.4. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.15. Rest of APAC
    • 10.4.15.1. Overview
    • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.15.3. Rest of APAC Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.4.15.4. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
• 10.5. Latin America
  • 10.5.1. Overview
  • 10.5.2. Cognitive Diagnostics Key Manufacturers in Latin America
  • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.5.4. Latin America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 10.5.5. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5.7. Brazil
    • 10.5.7.1. Overview
    • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.7.3. Brazil Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.5.7.4. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5.8. Mexico
    • 10.5.8.1. Overview
    • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.8.3. Mexico Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.5.8.4. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5.9. Argentina
    • 10.5.9.1. Overview
    • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.9.3. Argentina Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.5.9.4. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5.10. Colombia
    • 10.5.10.1. Overview
    • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.10.3. Colombia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.5.10.4. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5.11. Rest of LATAM
    • 10.5.11.1. Overview
    • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
• 10.6. Middle East and Africa
  • 10.6.1. Overview
  • 10.6.2. Cognitive Diagnostics Key Manufacturers in Middle East and Africa
  • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.6.4. Middle East and Africa Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  • 10.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6.7. Saudi Arabia
    • 10.6.7.1. Overview
    • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6.8. United Arab Emirates
    • 10.6.8.1. Overview
    • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6.9. Israel
    • 10.6.9.1. Overview
    • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.9.3. Israel Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.6.9.4. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6.10. Turkey
    • 10.6.10.1. Overview
    • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.10.3. Turkey Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.6.10.4. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6.11. Algeria
    • 10.6.11.1. Overview
    • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.11.3. Algeria Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.6.11.4. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6.12. Egypt
    • 10.6.12.1. Overview
    • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.12.3. Egypt Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.6.12.4. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6.13. Rest of MEA
    • 10.6.13.1. Overview
    • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.13.3. Rest of MEA Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.6.13.4. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Cognitive Diagnostics Industry

• 11.1. Competitive Dashboard
• 11.2. Company Profiles
  • 11.2.1. Cognetivity Neurosciences
  • 11.2.2. Cognivue
  • 11.2.3. Cogstate
  • 11.2.4. Cambridge Cognition
  • 11.2.5. Diadem
  • 11.2.6. CN Diagnostics
  • 11.2.7. Others

12. 360 Degree Analyst View

13. Appendix

• 13.1. Research Methodology
• 13.2. References
• 13.3. Abbreviations
• 13.4. Disclaimer
• 13.5. Contact Us